Skip to main content

Amedisys - Fundamentalanalyse - Jahresbericht / Bilanz / Geschäftsbericht

Amedisys (ISIN: US0234361089, WKN: 915582) Kursdatum: 21.07.2017 Kurs: 59,350 USD
Beschreibung Daten
Symbol AMED
Marktkapitalisierung 2.002.528.384,00 USD
Land Vereinigte Staaten von Amerika
Indizes NASDAQ Comp.
Sektor Gesundheitswesen
Rohdaten nach US GAAP in Millionen USD
Aktiensplits 2006-12-05 - 4:3 |
Internet
Letztes Bilanz Update 01.03.2017

Fundamentaldaten

Fundamental Verhältnisse errechnet am: 21.07.2017
KFCV KCV DIV Rendite GKR EKQ KGV KUV KBV
43,03 32,16 0,00% 5,06 62,70 53,96 1,39 4,35

Firmenbeschreibung

               16. UNAUDITED SUMMARIZED QUARTERLY FINANCIAL INFORMATION                        Net Income (Loss) Attributable to Amedisys, Inc. Common Stockholders (1)    Revenue Net Income (Loss) Attributable to Amedisys, Inc. Basic Diluted  2015:              1st Quarter (2) (3) $301.6 $(35.0) $(1.07) $(1.07)  2nd Quarter (3)  314.1  10.6  0.32  0.32  3rd Quarter (2) (3) (5)  326.4  8.4  0.25  0.25  4th Quarter (3) (4) (5)  338.4  12.9  0.39  0.38    $ 1,280.5 $(3.0) $(0.09) $(0.09)  2014:              1st Quarter (6) (7) $298.7 $(12.4) $(0.39) $(0.39)  2nd Quarter (8) (9)  305.0  7.6  0.24  0.23  3rd Quarter (9) (10)  300.3  8.4  0.26  0.26  4th Quarter (6)  300.5  9.1  0.28  0.28    $ 1,204.5 $12.8 $0.39 $0.39 Because of the method used in calculating per share data, the quarterly per share data may not necessarily total to the per share data as computed for the entire year.During the first quarter of 2015, we recorded a non-cash asset impairment charge to write-off the software costs incurred related to the development of AMS3 Home Health and Hospice in the amount of $45.5 million, net of income taxes. During the third quarter of 2015, we recorded a non-cash asset impairment charge related to our corporate headquarters in the amount of $1.2 million, net of income taxes.During each of the four quarters of 2015, we incurred certain costs associated with various legal matters. Net of income taxes, these costs amounted to $1.3 million, $4.8 million, $0.2 million and $(1.1) million for the three-month periods ended March 31, 2015, June 30, 2015, September 30, 2015 and December 31, 2015, respectively.During the fourth quarter of 2015, we recorded an accrual related to an OIG Self-Disclosure matter. Net of income taxes, this charge amounted to $3.4 million.During the third and fourth quarters of 2015, we incurred certain costs associated with the implementation of Homecare Homebase. Net of income taxes, these costs amounted to $1.2 million and $1.4 million for the three-month periods ended September 30, 2015 and December 31, 2015, respectively.During the first and fourth quarters of 2014, we recognized non-cash other intangibles impairment charges of $1.4 million and $0.6 million, net of income taxes. During the first quarter of 2014, we recorded charges for the accrual of various relators' attorneys' fees and expenses in connection with the settlement agreement to resolve the U.S. Department of Justice investigation and the Stark Law Self-Referral matter and exit and restructuring activity costs. Net of income taxes, these charges amounted to $2.4 million and $6.1 million, respectively.During the second quarter of 2014, we recorded an accrual related to an OIG Self-Disclosure matter. Net of income taxes, this charge amounted to $0.9 million. Additionally, our results included a software write-off in the amount of $0.9 million, net of income taxes.Our results for the second quarter of 2014, included a gain related to the sale of care centers in the amount of $1.3 million, net of income taxes. Our results for the three months ended September 30, 2014, included a loss related to the disposal of our in-patient facility in the amount of $0.3 million, net of income taxes. During the third quarter of 2014, we recorded a charge related to the write-off of deferred financing fees in the amount of $0.3 million, net of income taxes. 

Firmenstrategie

Principles of Consolidation These consolidated financial statements include the accounts of Amedisys, Inc., and our wholly owned subsidiaries. All significant intercompany accounts and transactions have been eliminated in our accompanying consolidated financial statements, and business combinations accounted for as purchases have been included in our consolidated financial statements from their respective dates of acquisition. In addition to our wholly owned subsidiaries, we also have certain equity investments that are accounted for as set forth below.

RevenueRecognitionPolicyTextBlock

Revenue Recognition

We earn net service revenue through our home health and hospice care centers by providing a variety of services almost exclusively in the homes of our patients. This net service revenue is earned and billed either on an episode of care basis, on a per visit basis or on a daily basis depending upon the payment terms and conditions established with each payor for services provided. We refer to home health revenue earned and billed on a 60-day episode of care as episodic-based revenue.

When we record our service revenue, we record it net of estimated revenue adjustments and contractual adjustments to reflect amounts we estimate to be realizable for services provided, as discussed below. We believe, based on information currently available to us and based on our judgment, that changes to one or more factors that impact the accounting estimates (such as our estimates related to revenue adjustments, contractual adjustments and episodes in progress) we make in determining net service revenue, which changes are likely to occur from period to period, will not materially impact our reported consolidated financial condition, results of operations, cash flows or our future financial results.

Home Health Revenue Recognition

Medicare Revenue

Net service revenue is recorded under the Medicare prospective payment system (“PPS”) based on a 60-day episode payment rate that is subject to adjustment based on certain variables including, but not limited to: (a) an outlier payment if our patient's care was unusually costly (capped at 10% of total reimbursement per provider number); (b) a low utilization payment adjustment (“LUPA”) if the number of visits was fewer than five; (c) a partial payment if our patient transferred to another provider or we received a patient from another provider before completing the episode; (d) a payment adjustment based upon the level of therapy services required (with various incremental adjustments made for additional visits, with larger payment increases associated with the sixth, fourteenth and twentieth visit thresholds); (e) adjustments to payments if we are unable to perform periodic therapy assessments; (f) the number of episodes of care provided to a patient, regardless of whether the same home health provider provided care for the entire series of episodes; (g) changes in the base episode payments established by the Medicare Program; (h) adjustments to the base episode payments for case mix and geographic wages; and (i) recoveries of overpayments. In addition, we make adjustments to Medicare revenue if we find that we are unable to produce appropriate documentation of a face to face encounter between the patient and physician.

We make adjustments to Medicare revenue to reflect differences between estimated and actual payment amounts, our discovered inability to obtain appropriate billing documentation or authorizations and other reasons unrelated to credit risk. We estimate the impact of such adjustments based on our historical experience, which primarily includes a historical collection rate of over 99% on Medicare claims, and record this estimate during the period in which services are rendered as an estimated revenue adjustment and a corresponding reduction to patient accounts receivable. Therefore, we believe that our reported net service revenue and patient accounts receivable will be the net amounts to be realized from Medicare for services rendered.

In addition to revenue recognized on completed episodes, we also recognize a portion of revenue associated with episodes in progress. Episodes in progress are 60-day episodes of care that begin during the reporting period, but were not completed as of the end of the period. We estimate this revenue on a monthly basis based upon historical trends. The primary factors underlying this estimate are the number of episodes in progress at the end of the reporting period, expected Medicare revenue per episode and our estimate of the average percentage complete based on visits performed. As of December 31, 2015 and 2014, the difference between the cash received from Medicare for a request for anticipated payment (“RAP”) on episodes in progress and the associated estimated revenue was immaterial and, therefore, the resulting credits were recorded as a reduction to our outstanding patient accounts receivable in our consolidated balance sheets for such periods.

Non-Medicare Revenue

Episodic-based Revenue. We recognize revenue in a similar manner as we recognize Medicare revenue for episodic-based rates that are paid by other insurance carriers, including Medicare Advantage programs; however, these rates can vary based upon the negotiated terms.

Non-episodic based Revenue. Gross revenue is recorded on an accrual basis based upon the date of service at amounts equal to our established or estimated per-visit rates, as applicable. Contractual adjustments are recorded for the difference between our standard rates and the contracted rates to be realized from patients, third parties and others for services provided and are deducted from gross revenue to determine net service revenue and are also recorded as a reduction to our outstanding patient accounts receivable. In addition, we receive a minimal amount of our net service revenue from patients who are either self-insured or are obligated for an insurance co-payment.

Hospice Revenue Recognition

Hospice Medicare Revenue

Gross revenue is recorded on an accrual basis based upon the date of service at amounts equal to the estimated payment rates. The estimated payment rates are daily or hourly rates for each of the four levels of care we deliver. The four levels of care are routine care, general inpatient care, continuous home care and respite care. Routine care accounts for 99%, 98%, and 99% of our total net Medicare hospice service revenue for 2015, 2014 and 2013, respectively. We make adjustments to Medicare revenue for an inability to obtain appropriate billing documentation or acceptable authorizations and other reasons unrelated to credit risk. We estimate the impact of these adjustments based on our historical experience, which primarily includes our historical collection rate on Medicare claims, and record it during the period services are rendered as an estimated revenue adjustment and as a reduction to our outstanding patient accounts receivable.

Additionally, as Medicare hospice revenue is subject to an inpatient cap limit and an overall payment cap for each provider number, we monitor these caps and estimate amounts due back to Medicare if we estimate a cap has been exceeded. We record these adjustments as a reduction to revenue and an increase in other accrued liabilities. Beginning for the cap year ending October 31, 2014, providers are required to self-report and pay their estimated cap liability by March 31st of the following year. As of December 31, 2015, we have settled our Medicare hospice reimbursements for all fiscal years through October 31, 2012 and we have recorded $1.4 million for estimated amounts due back to Medicare in other accrued liabilities for the Federal cap years ended October 31, 2013 through October 31, 2016. As of December 31, 2014, we had recorded $2.8 million for estimated amounts due back to Medicare in other accrued liabilities for the Federal cap years ended October 31, 2013 through October 31, 2015.

Hospice Non-Medicare Revenue

We record gross revenue on an accrual basis based upon the date of service at amounts equal to our established rates or estimated per day rates, as applicable. Contractual adjustments are recorded for the difference between our established rates and the amounts estimated to be realizable from patients, third parties and others for services provided and are deducted from gross revenue to determine our net service revenue and patient accounts receivable.

SegmentReportingDisclosureTextBlock

15. Segment Information

Our operations involve servicing patients through our two reportable business segments: home health and hospice. Our home health segment delivers a wide range of services in the homes of individuals who may be recovering from surgery, have a chronic disability or terminal illness or need assistance with the essential activities of daily living. Our hospice segment provides palliative care and comfort to terminally ill patients and their families. The “other” column in the following tables consists of costs relating to executive management and administrative support functions, primarily information services, accounting, finance, billing and collections, legal, compliance, risk management, procurement, marketing, clinical administration, training, human resources and administration.

Management evaluates performance and allocates resources based on the operating income of the reportable segments, which includes an allocation of corporate expenses directly attributable to the specific segment and includes revenues and all other costs directly attributable to the specific segment. Segment assets are not reviewed by the company's chief operating decision maker and therefore are not disclosed below (amounts in millions).

 

EarningsPerSharePolicyTextBlock

Weighted-Average Shares Outstanding

Net (loss) income per share attributable to Amedisys, Inc. common stockholders, calculated on the treasury stock method, is based on the weighted average number of shares outstanding during the period. The following table sets forth, for the periods indicated, shares used in our computation of the weighted-average shares outstanding, which are used to calculate our basic and diluted net earnings attributable to Amedisys, Inc. common stockholders (amounts in thousands):

        For the Year Ended December 31, 2015  
        Home Health     Hospice     Other     Total  
  Net service revenue   $ 1,005.1   $ 275.4   $ 0.0   $ 1,280.5  
  Cost of service, excluding depreciation and amortization     584.2     141.7     0.0     725.9  
  General and administrative expenses     263.2     62.7     126.5     452.4  
  Provision for doubtful accounts     12.2     1.9     0.0     14.1  
  Depreciation and amortization     5.2     1.4     13.4     20.0  
  Goodwill and other intangibles impairment charge     0.0     0.0     77.3     77.3  
  Operating expenses     864.8     207.7     217.2     1,289.7  
  Operating income (loss)   $ 140.3   $ 67.7   $ (217.2)   $ (9.2)  
                             
        For the Year Ended December 31, 2014  
        Home Health     Hospice     Other     Total  
  Net service revenue   $ 956.9   $ 247.6   $ 0.0   $ 1,204.5  
  Cost of service, excluding depreciation and amortization     559.4     131.7     0.0     691.1  
  General and administrative expenses     269.0     58.3     114.4     441.7  
  Provision for doubtful accounts     14.8     1.5     0.0     16.3  
  Depreciation and amortization     9.0     2.1     17.2     28.3  
  Goodwill and other intangibles impairment charge     1.6     1.5     0.0     3.1  
  Operating expenses     853.8     195.1     131.6     1,180.5  
  Operating income (loss)   $ 103.1   $ 52.5   $ (131.6)   $ 24.0  
                             
        For the Year Ended December 31, 2013  
        Home Health     Hospice     Other     Total  
  Net service revenue   $ 987.7   $ 261.6   $ 0.0   $ 1,249.3  
  Cost of service, excluding depreciation and amortization     578.9     139.1     0.0     718.0  
  General and administrative expenses     304.8     64.7     104.5     474.0  
  Provision for doubtful accounts     10.2     5.7     0.0     15.9  
  Depreciation and amortization     10.3     2.1     24.5     36.9  
  U.S. Department of Justice settlement     0.0     0.0     150.0     150.0  
  Goodwill and other intangibles impairment charge    
        For the Years Ended December 31,  
        2015   2014   2013  
  Weighted average number of shares outstanding - basic   33,018   32,301   31,247  
  Effect of dilutive securities:              
    Stock options   0   1   0  
    Non-vested stock and stock units   0   521   0  
  Weighted average number of shares outstanding - diluted   33,018   32,823   31,247  
  Anti-dilutive securities   922   106   688